The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

Great effort has been devoted to the synthesis of novel multi-target directed tacrine derivatives in the search of new treatments for Alzheimer’s disease (AD). Herein we describe the proof of concept of MBA121, a compound designed as a tacrine–ferulic acid hybrid, and its potential use in the therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Ruiz, Emelina R., Herrero-Labrador, Raquel, Fernández-Fernández, Ana P., Serrano-Masa, Julia, Martínez-Montero, José A., González-Nieto, Daniel, Hana-Vaish, Mayuri, Benchekroun, Mohamed, Ismaili, Lhassane, Marco-Contelles, José, Martínez-Murillo, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419016/
https://www.ncbi.nlm.nih.gov/pubmed/37569630
http://dx.doi.org/10.3390/ijms241512254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419016/
https://www.ncbi.nlm.nih.gov/pubmed/37569630
http://dx.doi.org/10.3390/ijms241512254

Ejemplares similares